Previously undisclosed pre-seed · Biotech
Atlas Bio discloses $2.5m pre-seed backing
First Momentum Ventures and LEA Partners co-led the earlier round, disclosed alongside the Swiss company’s new seed financing.
An earlier round brought into view
Atlas Bio has disclosed a previously unannounced $2.5 million pre-seed round co-led by First Momentum Ventures and LEA Partners. It announced the earlier financing alongside a separate $10 million seed round on October 27, taking total funding to $12.5 million.
Modelling drug responses
The Basel company builds AI models that simulate patient responses to treatments. Its work helps biopharma teams compare development paths and plan clinical studies. Simon Romanski and Sebastian Bayer founded Atlas Bio in 2024.
Funding history
Previously undisclosed pre-seed · This round$2.5M